HomeBUSINESS
BUSINESS

Janssen, Taiho to Copromote Psoriasis Med Guselkumab
(Dec.19.2017)

Taiho Pharmaceutical will copromote Janssen Pharmaceutical’s human monoclonal anti-interleukin (IL)-23 antibody guselkumab, which is pending approval in Japan for psoriasis and palmoplantar pustulosis (PPP), the two companies said on December 18 ...
(LOG IN FOR FULL STORY)

News Calendar